IDO1 and pulmonary arterial hypertension: IDO-TMs, and not tryptophane hydroxylase metabolites, were elevated in PAH and strongly correlated with RV-pulmonary vasculature dysfunction (resting RAP, PAP, PVR, exercise PVR and change in cardiac output during exercise) in a cohort of patients with PAH (291).